A. Benavides

TARGETING TORC 2 IN MULTIPLE MYELOMA WITH A NEW mTOR KINASE INHIBITOR Running title : TORC 2 and multiple myeloma

J. Gera, A. Lichtenstein, T. Guglielmelli, 2010 .

Effect of autophagy on multiple myeloma cell viability

A. Lichtenstein, B. Hoang, P. Frost, 2009, Molecular Cancer Therapeutics.

IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1.

J. Gera, A. Lichtenstein, B. Hoang, 2008, Cancer research.

IL-6-induced Enhancement of c-Myc Translation in Multiple Myeloma Cells

J. Gera, A. Lichtenstein, B. Hoang, 2010, The Journal of Biological Chemistry.

Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor.

J. Gera, A. Lichtenstein, T. Guglielmelli, 2010, Blood.

The PP242 Mammalian Target of Rapamycin (mTOR) Inhibitor Activates Extracellular Signal-regulated Kinase (ERK) in Multiple Myeloma Cells via a Target of Rapamycin Complex 1 (TORC1)/ Eukaryotic Translation Initiation Factor 4E (eIF-4E)/RAF Pathway and Activation Is a Mechanism of Resistance*

J. Gera, A. Lichtenstein, B. Hoang, 2012, The Journal of Biological Chemistry.

Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor.

J. Gera, A. Lichtenstein, T. Guglielmelli, 2010, Blood.

The PP242 Mammalian Target of Rapamycin (mTOR) Inhibitor Activates Extracellular Signal-regulated Kinase (ERK) in Multiple Myeloma Cells via a Target of Rapamycin Complex 1 (TORC1)/ Eukaryotic Translation Initiation Factor 4E (eIF-4E)/RAF Pathway and Activation Is a Mechanism of Resistance*

J. Gera, A. Lichtenstein, B. Hoang, 2012, The Journal of Biological Chemistry.